Market News How it works Learn FAQ
| RCT 0.132 73.46% | NU 12.36 -18.47% | EWZ 33.885 -20.44% | TGL 0.254 14.67% | SRTM 0.326 -24.24% | BBD 2.855 -29.85% | ITUB 7.6 -21.41% | AZTR 1.615 125.87% | SHFS 0.103 -22.21% | XP 15.575 -48.78% | GCDT 0.1361 -22.71% | CLRO 4.79 47.38% | SOXL 91.64 9.67% | SPCX 149.92 1.65% | NWGL 0.0829 1.10% | PBR 21.94 -16.13% | NVD 3.99 -4.77% | SGRY 23.0703 46.48% | TSLL 10.9599 12.29% | VALE 11.99 -3.31% | RBNE 0.1701 -10.47% | CRWV 57.4626 5.95% | INTC 90.785 4.40% | NVDA 216.2072 2.49% | SOXS 47.41 -9.63% | BITO 10.77 -0.55% | ABEV 2.8 -15.15% | IREN 26.5486 6.60% | JBLU 2.295 -12.57% | NOK 8.625 5.96% | XTND 2.2 24.29% | SPRC 1.5001 37.62% | GPUS 0.1782 5.51% | TQQQ 69.14 4.30% | SBS 4.765 -25.55% | INTR 4.6286 -35.62% | TSLG 5.48 12.53% | RWM 14.435 -0.79% | TSLA 395.443 6.24% | SPDN 8.475 -0.76% | SQQQ 37.975 -4.30% | AAL 12.2055 0.79% | SID 0.9269 -21.45% | GGB 4.765 -6.57% | PBR-A 19.3388 -17.81% | RENT 2.9015 26.15% | LUCD 0.5155 25.43% | CIFR 8.1475 2.61% | KORU 10.9537 3.53% | WULF 12.08 6.71%
BTBiotricity, Inc. logo

Biotricity, Inc. (BTCY)

Other OTC · Currency in USD
$0.05 ▼ -0.01 (-14.18%)
As of Oct 26, 10:58 AM ET. Market open.

Summary

Previous Close
$0.06
Open
$0.05
Day's Range
$0.05 – $0.05
52 Week Range
$0.04 – $0.65
Volume
6
Avg. Volume
36,378
Market Cap
$939.94K
Beta (5Y Monthly)
1.22
PE Ratio (TTM)
--
EPS (TTM)
-$0.12
Earnings Date
Nov 12, 2026
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
$4.00

Profile: Biotricity, Inc.

Sector
Healthcare
Industry
Medical - Devices
Full-time employees
46
CEO
Waqaas Al-Siddiq

Headquartered in Redwood City, California, Biotricity, Inc. is a medical technology enterprise delivering biometric data monitoring solutions, primarily within the United States. The company's efforts are dedicated to supplying remote monitoring capabilities to the medical, healthcare, and individual consumer markets, encompassing both diagnostic tools and ongoing management support for chronic and lifestyle-related conditions. Among its key offerings are the Bioflux mobile cardiac telemetry solution, an integrated ECG device, alongside specialized ECG analysis software designed to process and synthesize patient heart rhythm data, complemented by various software components.

Earnings

Next report: Thu, Nov 12, 2026
DateEst.Actual
Aug 19, 2026–-$0.05
Jul 17, 2026-$0.08-$0.02Beat
Feb 11, 2026-$0.08-$0.04Beat
Nov 14, 2025-$0.08-$0.03Beat
Aug 14, 2025-$0.09-$0.03Beat
Jun 25, 2025-$0.10$0.02Beat

Analyst view

Consensus price target
$4.00 ▲ +8,374.6%
Range $4.00 – $4.00
Rating: Buy
Buy 50% · Hold 50% · Sell 0%

Get free alerts on BTCY and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.